| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |